The Quo-Test HbA1c now provides results in percentages and millimoles per mol, helping users to make the transition from DCCT-aligned reporting to the new IFCC reference method.
Quo-Test has been developed for use in the primary-care environment to provide rapid, precise and accurate HbA1c results to help people with diabetes to keep their blood-glucose levels under control.
With minimum handling and automatic calibration, measurements are simple to perform and results are displayed, printed or downloaded in less than 4min.
A small footprint and low weight also mean that it can be easily transported to satellite facilities, outreach clinics or other community settings.
Quo-Test is one of the first analysers to report the IFCC reference method values that have been introduced to improve the consistency in HbA1c reporting.
Improved standardisation will make it easier to compare results from different labs throughout the world and interpret clinical-trial data.
A year-year transition period is underway where results will be reported in DCCT and IFCC values, allowing people with diabetes and healthcare workers to become familiar with mmol/mol before the full changeover on 1 April 2011.
The Quo-Test will also continue to offer the possibility to report results in IFCC percentage, JDS percentage and Mono-S percentage.
Quo-Test A1C is traceable to the DCCT reference method and has been certified by the National Glycohaemoglobin Standardization Programme (NGSP).
